Personal Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $624K | Sell |
7,266
-800
| -10% | -$68.7K | ﹤0.01% | 272 |
|
|
2022
Q3 | $498K | Buy |
8,066
+16
| +0.2% | +$988 | ﹤0.01% | 285 |
|
|
2022
Q2 | $498K | Buy |
8,050
+145
| +2% | +$8.97K | ﹤0.01% | 275 |
|
|
2022
Q1 | $470K | Sell |
7,905
-440
| -5% | -$26.2K | ﹤0.01% | 316 |
|
|
2021
Q4 | $606K | Buy |
8,345
+176
| +2% | +$12.8K | ﹤0.01% | 308 |
|
|
2021
Q3 | $571K | Buy |
8,169
+3,124
| +62% | +$218K | ﹤0.01% | 295 |
|
|
2021
Q2 | $347K | Sell |
5,045
-560
| -10% | -$38.5K | ﹤0.01% | 369 |
|
|
2021
Q1 | $362K | Sell |
5,605
-167
| -3% | -$10.8K | ﹤0.01% | 357 |
|
|
2020
Q4 | $336K | Buy |
5,772
+529
| +10% | +$30.8K | ﹤0.01% | 362 |
|
|
2020
Q3 | $331K | Buy |
5,243
+144
| +3% | +$9.09K | ﹤0.01% | 316 |
|
|
2020
Q2 | $392K | Sell |
5,099
-959
| -16% | -$73.7K | ﹤0.01% | 269 |
|
|
2020
Q1 | $406K | Buy |
6,058
+319
| +6% | +$21.4K | ﹤0.01% | 266 |
|
|
2019
Q4 | $373K | Buy |
5,739
+633
| +12% | +$41.1K | ﹤0.01% | 300 |
|
|
2019
Q3 | $323K | Sell |
5,106
-530,048
| -99% | -$33.5M | ﹤0.01% | 285 |
|
|
2019
Q2 | $36.2M | Buy |
535,154
+63,925
| +14% | +$4.32M | 0.37% | 71 |
|
|
2019
Q1 | $30.6M | Buy |
471,229
+71,319
| +18% | +$4.64M | 0.34% | 76 |
|
|
2018
Q4 | $25M | Sell |
399,910
-65,400
| -14% | -$4.09M | 0.33% | 74 |
|
|
2018
Q3 | $35.9M | Buy |
465,310
+25,825
| +6% | +$1.99M | 0.46% | 53 |
|
|
2018
Q2 | $31.1M | Buy |
439,485
+48,741
| +12% | +$3.45M | 0.44% | 59 |
|
|
2018
Q1 | $29.5M | Buy |
+390,744
| New | +$29.5M | 0.46% | 54 |
|